Alembic Ltd
Ticker: ALEMBICLTD
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
99.66
Market Cap
2559.09
Debt/Equity
0.0062
ROE %
13.734
PB
1.0943
Promoter %
70.882
Pledge %
0.000
1Y Rev Growth %
39.819
5Y Rev Growth %
12.143
NP Margin %
104.684
NP Margin 5Y Avg %
174.519
Trading Reference
1M Return %
-6.074
6M Return %
-3.961
1Y Return %
-28.256
% Away 52W High
53.913
% Away 52W Low
16.616
Daily Volume
207465
Investment Verdict
Buy
Score 87/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Alembic Ltd is currently trading near a key support level, with the 50-day EMA showing a bullish crossover above the 200-day EMA. Volume has been increasing on upward price movements, indicating strong buying interest. Therefore, there is a favorable outlook for the next 6-12 months, with potential for price appreciation towards resistance levels.
Upside Probability: 15% | Downside Probability: 5%
Probability estimates are technical-context statements, not investment advice.
More Options
P
Pokarna Ltd
Pokarna Ltd shows decent potential with stable growth prospects, but investors should be cautious of execution risks and market competition.
View details
S
Sirca Paints India Ltd
While Sirca Paints operates in a promising sector, the company faces challenges in profitability and valuation, suggesting a cautious approach.
View details
N
Nitco Ltd
Nitco Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
L
Landmark Cars Ltd
Landmark Cars Ltd shows potential in a growing sector but faces challenges in profitability and valuation metrics. Caution is advised.
View details
S
SBI Gold ETF
SBI Gold ETF presents a decent investment opportunity with stable growth prospects, but investors should be cautious of market volatility and execution risks.
View details
K
KCP Ltd
KCP Ltd presents a risky investment profile due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
H
Hathway Cable and Datacom Ltd
Hathway Cable and Datacom Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability.
View details
B
Bhansali Engineering Polymers Ltd
While Bhansali Engineering Polymers Ltd shows potential for growth, there are several risks that investors should consider before investing.
View details
M
Marine Electricals (India) Ltd
Marine Electricals (India) Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks and market sentiment.
View details
L
LS Industries Ltd
LS Industries Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
P
Panacea Biotec Ltd
Panacea Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
A
Automotive Axles Ltd
Automotive Axles Ltd presents a mixed outlook with significant risks overshadowing potential growth opportunities.
View details
C
Carraro India Ltd
Carraro India Ltd shows potential in a growing sector, but faces challenges in consistent growth and market sentiment.
View details
Y
Yatra Online Ltd
Yatra Online Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
Nippon India ETF Nifty 1D Rate Liquid BeES
The Nippon India ETF Nifty 1D Rate Liquid BeES shows decent potential with stable growth and profitability metrics, but faces challenges in governance and growth drivers.
View details
R
RIR Power Electronics Ltd
RIR Power Electronics Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
Business Overview
Alembic Ltd is a prominent Indian pharmaceutical company dedicated to delivering high-quality healthcare solutions. With a strong focus on research and development, it caters to both domestic and international markets. The company is committed to innovation and sustainability, making it a trusted choice for healthcare professionals and patients alike. Alembic's extensive product portfolio and robust manufacturing capabilities ensure reliability and excellence in every aspect of its operations.
- Established player in the pharmaceutical sector
- Strong emphasis on R&D and innovation
- Wide range of quality healthcare products
- Global presence with trusted reputation
- Commitment to sustainability and ethical practices
Investment Thesis
Alembic Ltd stands out as a compelling investment due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. The company's commitment to innovation and expansion positions it well for future growth, making it a valuable addition to any portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services sector, tapping into evolving market demands.
- Attractive valuation metrics compared to industry peers, offering potential for capital appreciation.
- Established brand with a diversified product portfolio ensures stability and growth.
- Commitment to R&D positions Alembic for sustained innovation and competitive advantage.
Opportunity vs Risk
Opportunities
- Strong growth in pharmaceutical sector
- Expanding product portfolio
- Rising demand for generics
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory changes impact operations
- Intense competition in market
- Dependence on key suppliers
- Fluctuating raw material costs
Peer Perspective
Alembic Ltd trades at a premium to peers like Sun Pharma and Lupin, reflecting its strong growth potential. A sustained improvement in margin stability could trigger a re-rating, aligning it closer to sector leaders.
Future Outlook
Alembic Ltd is well-positioned for growth, driven by strong product pipelines and market demand; however, successful execution and effective cost control will be crucial to fully realize its potential in the coming quarters.
AI FAQs for Retail Users
- Q: What does Alembic Ltd do?A: Alembic Ltd is involved in pharmaceuticals, manufacturing a range of generic and branded medicines.
- Q: Is Alembic Ltd a good investment?A: Investment decisions should be based on individual research and financial goals; consult a financial advisor.
- Q: What are the risks of investing in Alembic Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy Alembic Ltd shares?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is Alembic Ltd's dividend policy?A: Alembic Ltd has a history of paying dividends, but future payments depend on company performance.
📊 Stock Investment Checklist (100 Points)
Alembic Ltd • Updated: 2025-09-17 01:09:54
-
10BusinessHighPharmaceutical sector shows potential, but competition is high.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Alembic Ltd shows potential for growth, but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100